We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
-0.85%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$471B
AUM Growth
+$25.1B
Cap. Flow
+$36.8B
Cap. Flow %
7.8%
Top 10 Hldgs %
18.87%
Holding
6,784
New
621
Increased
2,690
Reduced
2,234
Closed
596

Sector Composition

Rank Sector Weight
1 Technology 15.7%
2 Consumer Discretionary 9.53%
3 Financials 8.37%
4 Healthcare 7.77%
5 Communication Services 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XELA
5476
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$276K ﹤0.01%
36
-118
-77% -$1.21M
AXGN icon
5477
Axogen
AXGN
$2.42B
$275K ﹤0.01%
17,387
-1,910
-10% -$34.3K
HOFT icon
5478
Hooker Furnishings Corp
HOFT
$161M
$274K ﹤0.01%
10,162
-8,939
-47% -$286K
SPLV icon
5479
CALL
Invesco S&P 500 Low Volatility ETF
SPLV
$7.21B
$274K ﹤0.01%
+4,500
New +$284K
CBAY
5480
CALL
DELISTED
Cymabay Therapeutics
CBAY
$274K ﹤0.01%
+75,000
New +$295K
CBAY
5481
PUT
DELISTED
Cymabay Therapeutics
CBAY
$274K ﹤0.01%
+75,000
New +$295K
EEX
5482
DELISTED
Emerald Holding
EEX
$273K ﹤0.01%
62,793
-7,067
-10% -$31.7K
ZYNE
5483
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$273K ﹤0.01%
64,468
+9,586
+17% +$42.8K
KDMN
5484
PUT
DELISTED
Kadmon Holdings, Inc.
KDMN
$273K ﹤0.01%
+31,300
New +$178K
PRLD icon
5485
Prelude Therapeutics
PRLD
$362M
$271K ﹤0.01%
8,659
-9,958
-53% -$322K
USX
5486
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$271K ﹤0.01%
31,426
+1,813
+6% +$15.7K
EVLO
5487
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$271K ﹤0.01%
1,925
+586
+44% +$116K
TIG
5488
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
$271K ﹤0.01%
26,210
-8,229
-24% -$97.8K
ATHX
5489
DELISTED
Athersys, Inc. Common Stock
ATHX
$271K ﹤0.01%
8,142
-10,633
-57% -$404K
ADMA icon
5490
ADMA Biologics
ADMA
$2.12B
$270K ﹤0.01%
238,345
+95,540
+67% +$134K
LAUR icon
5491
PUT
Laureate Education
LAUR
$5.27B
$270K ﹤0.01%
+15,900
New +$250K
SGTX
5492
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$270K ﹤0.01%
3,682
+1,101
+43% +$84.7K
PLSE icon
5493
Pulse Biosciences
PLSE
$2.58B
$269K ﹤0.01%
12,456
+1,244
+11% +$26.8K
PFSW
5494
DELISTED
PFSweb, Inc.
PFSW
$269K ﹤0.01%
+20,834
New +$260K
DXLG icon
5495
Destination XL Group
DXLG
$31.3M
$268K ﹤0.01%
+43,719
New +$277K
GGAL icon
5496
Galicia Financial Group
GGAL
$7.83B
$267K ﹤0.01%
26,479
+8,258
+45% +$75.6K
VOSO
5497
DELISTED
Virtuoso Acquisition Corp. Class A Common Stock
VOSO
$267K ﹤0.01%
26,929
-211,216
-89% -$2.09M
HIFS icon
5498
Hingham Institution for Saving
HIFS
$666M
$266K ﹤0.01%
789
-1,933
-71% -$604K
YALA
5499
Yalla Group
YALA
$820M
$265K ﹤0.01%
34,900
+2,500
+8% +$29.1K
MOON
5500
DELISTED
Direxion Moonshot Innovators ETF
MOON
$265K ﹤0.01%
+8,307
New +$275K

Similar funds

Goldman Sachs's Q3 2021 Portfolio in Review

As of Q3 2021, Goldman Sachs held 6,784 positions worth $471B, up 5.6% from $446B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Goldman Sachs deployed $36.8B of net new capital in Q3 2021, opening 621 new positions and adding to 2,690 existing holdings. Its largest new stake was Sterling Check Corp. Common Stock: 59,953,230 shares worth $1.56B.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $928M trimmed.

  • Goldman Sachs's largest Q3 2021 buy was Sterling Check Corp. Common Stock: 59,953,230 shares worth $1.56B.
  • Goldman Sachs added most to Alibaba in Q3 2021, an estimated $3.18B increase.
  • Goldman Sachs's biggest Q3 2021 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $928M.
  • Goldman Sachs fully exited Brookfield Property Partners L.P. Limited Partnership Units in Q3 2021, selling an estimated $327M.
  • Goldman Sachs's ten largest holdings make up 19% of its $471B portfolio in Q3 2021.
  • Goldman Sachs opened 621 new positions and closed 596 in Q3 2021.
  • Goldman Sachs's portfolio value rose 5.6% quarter-over-quarter to $471B.

Based on Goldman Sachs's 13F filing for Q3 2021, filed 10 Nov 2021.